StockData
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. (TARS) stock

TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/304% above fair value
$78.20−0.48 (-0.61%)

Close on Nov 17, 2026Market cap $3.43BP/E –Yield 0.00%

Tarsus Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202693.0%−7.0
Q1 FY2026Mar 31, 202694.2%−2.4
Q2 FY2025Jun 30, 202593.9%+0.0
Q1 FY2025Mar 31, 202593.3%−1.4
Q1 FY2023Mar 31, 2023100.0%–
Q2 FY2022Jun 30, 202296.6%–
Q1 FY2022Mar 31, 202293.9%–
Q3 FY2021Sep 30, 202194.8%–

More Tarsus Pharmaceuticals figures

See a number that looks wrong?